CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
| Image |  |
|---|---|
| Description | scientific article published on 8 September 2017 |
| Author/s |
author: Simone Brixius-Anderko Sameer S Udhane Amit V. Pandey Rita Bernhardt |
| Publication date | September 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |